Map Light Therapeutics, Inc. MPLT
We take great care to ensure that the data presented and summarized in this overview for MapLight Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MPLT
Top Purchases
Top Sells
About MPLT
Insider Transactions at MPLT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2025
|
Novo Holdings |
BUY
Open market or private purchase
|
Direct |
952,941
+20.54%
|
$16,199,997
$17.0 P/Share
|
|
Oct 28
2025
|
Novo Holdings |
BUY
Conversion of derivative security
|
Direct |
2,733,681
+50.0%
|
-
|
|
Oct 28
2025
|
Catalyst4, Inc. |
BUY
Open market or private purchase
|
Indirect |
5,441,176
+21.64%
|
$92,499,992
$17.0 P/Share
|
|
Oct 28
2025
|
Catalyst4, Inc. |
BUY
Conversion of derivative security
|
Indirect |
14,256,288
+50.0%
|
-
|
|
Oct 28
2025
|
Christopher A. Kroeger Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
3,895
+1.67%
|
-
|
|
Oct 28
2025
|
Robert C. Malenka |
BUY
Conversion of derivative security
|
Indirect |
3,895
+10.95%
|
-
|
|
Oct 27
2025
|
Christopher A. Kroeger Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,693
+50.0%
|
-
|
|
Oct 27
2025
|
Robert C. Malenka |
BUY
Grant, award, or other acquisition
|
Direct |
34,390
+7.92%
|
-
|
|
Oct 27
2025
|
Erin Pennock Foff Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,275
+50.0%
|
-
|
|
Oct 27
2025
|
Setia Vishwas Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,367
+50.0%
|
-
|
|
Oct 27
2025
|
James Woodruff Lillie Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,539
+50.0%
|
-
|
|
Oct 27
2025
|
Anatol Kreitzer Chief Discovery Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,953
+50.0%
|
-
|
|
Oct 27
2025
|
Jonathan Gillis CAAO and PAO |
BUY
Grant, award, or other acquisition
|
Direct |
30,565
+50.0%
|
-
|
|
Oct 27
2025
|
Kristopher Hanson General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
27,098
+50.0%
|
-
|
|
Oct 27
2025
|
Maria C Walker |
BUY
Grant, award, or other acquisition
|
Direct |
6,294
+50.0%
|
-
|
|
Oct 27
2025
|
Timothy John Garnett |
BUY
Grant, award, or other acquisition
|
Direct |
6,294
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
23.9M
Shares
From
16
Insiders
| Conversion of derivative security | 17M shares |
|---|---|
| Open market or private purchase | 6.39M shares |
| Grant, award, or other acquisition | 490K shares |
Sell / Disposition
0
Shares
From
0
Insiders